Parmar, Simrit <br/><br/>
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2011 
 - 294-302 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.30.6357  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Deaminase Inhibitors--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Intention to Treat Analysis<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Pentostatin--administration & dosage<br/>Survival Analysis<br/>Tacrolimus--administration & dosage<br/>Transplantation Conditioning--methods